Chemoinformaics analysis of 5-HYDROXY-7-(4-HYDROXY-3-METHOXYPHENYL)-1-PHENYL-HEPTANONE
| Molecular Weight | 328.408 | nRot | 9 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 13 |
| Exact Molecular Weight | 328.167 | nRing | 2 |
| Solubility: LogS | -3.638 | nHRing | 0 |
| Solubility: LogP | 2.5 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 52.611 |
| nHD | 2 | BPOL | 26.681 |
| QED | 0.741 |
| Synth | 2.486 |
| Natural Product Likeliness | 1.147 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.912 |
| Pgp-sub | 0.997 |
| HIA | 0.022 |
| CACO-2 | -4.682 |
| MDCK | 0.0000204 |
| BBB | 0.226 |
| PPB | 0.953039 |
| VDSS | 0.836 |
| FU | 0.0169914 |
| CYP1A2-inh | 0.714 |
| CYP1A2-sub | 0.93 |
| CYP2c19-inh | 0.907 |
| CYP2c19-sub | 0.459 |
| CYP2c9-inh | 0.715 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.699 |
| CYP2d6-sub | 0.884 |
| CYP3a4-inh | 0.363 |
| CYP3a4-sub | 0.561 |
| CL | 14.728 |
| T12 | 0.927 |
| hERG | 0.12 |
| Ames | 0.178 |
| ROA | 0.018 |
| SkinSen | 0.595 |
| Carcinogencity | 0.074 |
| EI | 0.419 |
| Respiratory | 0.088 |
| NR-Aromatase | 0.05 |
| Antiviral | No |
| Prediction | 0.670411 |